Dripping Rainfall Simulators for Soil Research—Design Review

Dripping rainfall simulators are important instruments in soil research. However, a large number of non-standardized simulators have been developed, making it difficult to combine and compare the results of different studies in which they were used. To overcome this problem, it is necessary to become familiar with the design and performances of the current rainfall simulators. A search has been conducted for scientific papers describing dripping rainfall simulators (DRS) and papers that are thematically related to the soil research using DRS. Simulator design analysis was performed integrally, for simulators with more than one dripper (DRS>1) and with one dripper (DRS=1). Descriptive and numerical data were extracted from the papers and sorted by proposed categories, according to which the types and subtypes of used simulators are determined. The six groups of elements that simulators could consist of have been determined, as well their characteristics, representation and statistical analyses of the available numerical parameters. The characteristics of simulators are analyzed and presented, facilitating the selection of simulators for future research. Description of future simulators in accordance to the basic groups of simulator elements should provide all data necessary for their easier replication and provide a step closer to the reduction of design diversification and standardization of rainfall simulators intended for soil research

Interferon Impedes an Early Step of Hepatitis Delta Virus Infection

Hepatitis delta virus (HDV) infects hepatocytes, the major cell type of the liver. Infection of the liver may be either transient or chronic. The prognosis for patients with chronic HDV infection is poor, with a high risk of cirrhosis and hepatocellular carcinoma. The best antiviral therapy is weekly administration for at least one year of high doses of interferon alpha. This efficacy of interferon therapy has been puzzling in that HDV replication in transfected cell lines is reported as insensitive to administration of interferon alpha or gamma. Similarly, this study shows that even when an interferon response was induced by transfection of poly(IC) into a cell line, HDV RNA accumulation was only modestly inhibited. However, when the HDV replication was initiated by infection of primary human hepatocytes, simultaneous addition of interferons alpha or gamma at 600 units/ml, a concentration comparable to that achieved in treated patients, the subsequent HDV RNA accumulation was inhibited by at least 80%. These interferon treatments were shown to produce significant time-dependent increases of host response proteins such as for Stat-1, phosphoStat-1, Mx1/2/3 and PKR, and yet interferon pretreatment of hepatocytes did not confer an increased inhibition of HDV replication over interferon treatment at the time of (or after) infection. These and other data support the interpretation that interferon action against HDV replication can occur and is largely mediated at the level of entry into primary human hepatocytes. Thus in vivo, the success of long-term interferon therapy for chronic HDV, may likewise involve blocking HDV spread by interfering with the initiation of productive infection of naïve hepatocytes

Updated site compilation of the Latin American Pollen Database

Flantua, Suzette G A et al.The updated inventory of the Latin American Pollen Database (LAPD) offers a wide range of new insights. This paper presents a systematic compilation of palynological research in Latin America. A comprehensive inventory of publications in peer-reviewed and grey literature shows a major expansion of studies over the last decades. The inventory includes 1379 cores and sections with paleoecological data and more than 4800 modern samples from throughout the continent. Through the years, pollen datasets extend over increasing spans of time and show improved taxonomic and temporal resolution. Currently, these datasets are from 12 modern biomes and 30 countries, covering an altitudinal range of 0 to 6300. m asl. The most densely sampled regions are the Colombian Andes, the southeast coast of Brazil, and Patagonia. Underrepresented biomes are the warm temperate mixed forest (3%), dry forests (3%), and warm temperate rainforest (1%); whereas steppe, tropical rainforest, and cool grass shrublands, such as the páramos, are generally well represented (all >. 17%). There are 126 records that span the late Pleistocene to the Last Glacial Maximum transition (21,000. cal. yr BP), and >. 20% of the records cover the Younger Dryas interval and the Pleistocene/Holocene transition. Reanalysis of numerous sites using multiproxy tools emphasize the informative value of this approach in paleoenvironmental reconstruction. We make suggestions for several pollen sites and regions to be visited again; similarly we identify some key research questions that have yet to be answered. The updated LAPD now provides the platform to support an exciting new phase of global palynological research in which multi-site data are being integrated to address current cutting-edge research questions. The LAPD compilation of sites and the literature database will be available through the Neotoma Paleoecology Database website and a new LAPD website by the end of 2015We thank the Netherlands Organization for Scientific Research (NWO, grant 2012/13248/ALW) for financial support of this project.Peer reviewe

Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction

Introduction Patients with cancer who develop small bowel obstruction are at high risk of malnutrition and morbidity following compromise of gastrointestinal tract continuity. This study aimed to characterise current management and outcomes following malignant small bowel obstruction. Methods A prospective, multicentre cohort study of patients with small bowel obstruction who presented to UK hospitals between 16th January and 13th March 2017. Patients who presented with small bowel obstruction due to primary tumours of the intestine (excluding left-sided colonic tumours) or disseminated intra-abdominal malignancy were included. Outcomes included 30-day mortality and in-hospital complications. Cox-proportional hazards models were used to generate adjusted effects estimates, which are presented as hazard ratios (HR) alongside the corresponding 95% confidence interval (95% CI). The threshold for statistical significance was set at the level of P ≤ 0.05 a-priori. Results 205 patients with malignant small bowel obstruction presented to emergency surgery services during the study period. Of these patients, 50 had obstruction due to right sided colon cancer, 143 due to disseminated intraabdominal malignancy, 10 had primary tumours of the small bowel and 2 patients had gastrointestinal stromal tumours. In total 100 out of 205 patients underwent a surgical intervention for obstruction. 30-day in-hospital mortality rate was 11.3% for those with primary tumours and 19.6% for those with disseminated malignancy. Severe risk of malnutrition was an independent predictor for poor mortality in this cohort (adjusted HR 16.18, 95% CI 1.86 to 140.84, p = 0.012). Patients with right-sided colon cancer had high rates of morbidity. Conclusions Mortality rates were high in patients with disseminated malignancy and in those with right sided colon cancer. Further research should identify optimal management strategy to reduce morbidity for these patient groups

National prospective cohort study of the burden of acute small bowel obstruction

Background Small bowel obstruction is a common surgical emergency, and is associated with high levels of morbidity and mortality across the world. The literature provides little information on the conservatively managed group. The aim of this study was to describe the burden of small bowel obstruction in the UK. Methods This prospective cohort study was conducted in 131 acute hospitals in the UK between January and April 2017, delivered by trainee research collaboratives. Adult patients with a diagnosis of mechanical small bowel obstruction were included. The primary outcome was in‐hospital mortality. Secondary outcomes included complications, unplanned intensive care admission and readmission within 30 days of discharge. Practice measures, including use of radiological investigations, water soluble contrast, operative and nutritional interventions, were collected. Results Of 2341 patients identified, 693 (29·6 per cent) underwent immediate surgery (within 24 h of admission), 500 (21·4 per cent) had delayed surgery after initial conservative management, and 1148 (49·0 per cent) were managed non‐operatively. The mortality rate was 6·6 per cent (6·4 per cent for non‐operative management, 6·8 per cent for immediate surgery, 6·8 per cent for delayed surgery; P = 0·911). The major complication rate was 14·4 per cent overall, affecting 19·0 per cent in the immediate surgery, 23·6 per cent in the delayed surgery and 7·7 per cent in the non‐operative management groups (P < 0·001). Cox regression found hernia or malignant aetiology and malnutrition to be associated with higher rates of death. Malignant aetiology, operative intervention, acute kidney injury and malnutrition were associated with increased risk of major complication. Conclusion Small bowel obstruction represents a significant healthcare burden. Patient‐level factors such as timing of surgery, acute kidney injury and nutritional status are factors that might be modified to improve outcomes